AIDX

0.157113.01%
JG

John G. Compton

Independent Chairman

Dr. John G. Compton, Ph.D. served as the Co-Founder, Chief Executive Officer, Co-President, Scientific Director Consultant and Principal of BRLI No. 2 Acquisition Corp. (Alternate Name GeneDx, Inc). Dr. Compton served as the Consultant and CSO of Genedx of Bio-Reference Laboratories Inc. He has experience in the development and application of molecular biological techniques to answer questions about genetics and epidermal differentiation. Dr. Compton served as an independent investigator of the Jackson Laboratory for six years. He joined the Laboratory of Skin Biology in the NIAMS at the NIH in 1991, where he served as Staff Scientist in the Genetic Studies Section until 2000. He is on the boards of the Pinkney Center for Science and Technology at Montgomery College - Germantown Campus and the Gaithersburg Germantown Upcounty Chamber of Commerce. He formed GeneDx with his NIH colleague to develop and provide molecular genetic testing in rare hereditary disorders. His work on the molecular genetics of inherited skin disease and expertise in laboratory methodology is known throughout the world. Dr. Compton is in his eighth year as Mayor of the Town of Washington Grove, MD. He has been an Independent Chairman at 20/20 Biolabs, Inc. since July 2016. He has authored more than 60 publications in the field. In 2003, he was awarded the Entrepreneur of the Year award by the Technology Council of Maryland. Dr. Compton holds B.S. degrees in Physics and Biology from MIT, received his Ph.D. from the University of California, Berkeley in Biophysics and did his post-doctoral training in protein-DNA interactions at the Baylor College of Medicine.

Positions